Greenphire announced the release of new visual analytics functionality for its eClinicalGPS technology.
Greenphire, the leading provider of payment technologies for the clinical trials industry, today announced the release of new visual analytics functionality for its eClinicalGPS technology. The new functionality is designed to empower Greenphire's clients to transform the clinical payment management process into a method of aggregating strategic data that enables more effective clinical trial forecasting, planning, tracking and quantitative assessment across all of their studies.
With the enhanced analytics functionality, clients will gain never-before-available insights into the financial health of their studies. By linking key cost drivers like subject enrollment and site-level clinical activity to contract and other financial data, clients are able to make more effective business decisions, in real-time, that ensure a trial is completed on-time and on-budget. Clients can also track actual costs versus budgets and create projections at a site, country, single-study, multi-study or therapeutic-area level.
The new features will build on eClinicalGPS's ability to dramatically reduce the administrative processes, service-based payment management expense, and risks associated with manual processing of investigator payments while simultaneously increasing site satisfaction and ensuring compliance with global transparency regulations.
"eClinicalGPS collects a large volume of contract, study-performance and financial data throughout the course of a clinical trial, and we're very excited to release new functionality to help our clients make this data actionable. By enabling our clients to visualize trends, instantly identify cost or performance issues, and model what-if scenarios, we help to ensure successful study execution. We're very excited to see what 'big data' can do for our clients," said David Wallace, Greenphire's Chief Technology Officer.
Sam Whitaker, co-founder and CEO of Greenphire, added, "With the increasing complexity of clinical trials and the concurrent pressure to keep costs down, any tool that can help our clients stay on top of the financial health of a study is essential. Although our eClinicalGPS has always provided access to data and reporting, the visual representation of the underlying eClinicalGPS data now enables our clients to more effectively understand trends and operational scenarios, in real-time, to strategically manage clinical studies."
For further information on Greenphire and its innovative solutions please email: [email protected] or visit www.greenphire.com.
Unlock Commercial Growth through Data-Driven Patient and HCP Insights
May 2nd 2025Leveraging data-driven patient and healthcare provider (HCP) insights, including social drivers of health (SDOH), is essential for life sciences companies to continuously improve patient engagement and commercial success. Mark Rodgers, AVP of Commercial Analytics at Inovalon, discusses how identifying treatment milestones, assessing HCP performance, and segmenting patient populations using SDOH data can drive targeted strategies that improve healthcare outcomes and market access
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.